Media Summary: Educo Life Sciences' trainer Melody discusses On October 22, 2025, the MRCT Center convened stakeholders from across the clinical research ecosystem at Ropes & Gray in ... Gary L. Simmons, DO, MSHA—physician and entrepreneur in a Virginia community practice—dives into the rapidly evolving world ...

Three Challenges When Developing A Cell And Gene Therapy Margit Holzer - Detailed Analysis & Overview

Educo Life Sciences' trainer Melody discusses On October 22, 2025, the MRCT Center convened stakeholders from across the clinical research ecosystem at Ropes & Gray in ... Gary L. Simmons, DO, MSHA—physician and entrepreneur in a Virginia community practice—dives into the rapidly evolving world ... Christopher Bravery Ph.D., Director of Consulting at Advanced Biologicals Ltd., explains how to overcome the This month's Insights Corner highlights how The global pharmaceutical industry is constantly innovating, looking forward to discover the next class of

The dynamic landscape of molecular biology has bolstered Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ... Akshay Sharma, MBBS, MSc, St. Jude Children's Research Hospital, Memphis, TN, highlights the main benefits of On Tuesday May 6, 2025, The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT ...

Photo Gallery

Three Challenges When Developing a Cell and Gene Therapy - Margit Holzer
Three Challenges When Developing a Cell and Gene Therapy - Melody Janssen
Top Three Tips When Moving into Cell & Gene Therapies - Margit Holzer
Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’
2025 MRCT Center Annual Symposium  |  Panel 03: Cell and Gene Therapies Long-Term Follow-Up (LTFU)
Cell and Gene Therapy (CGT) in the Community: Challenges and Opportunities
Three challenges to commercializing cell therapy
Biopharmaceutical Career Advice with Margit Holzer - Future Trends
FDA Roundtable on Cell and Gene Therapy
Gene Therapy Landscape From the World of CGT (Part-2)
Cell & Gene Therapy Trailblazers - Process Development - Chapter 3: ‘DELIVER TO GMP’
Cell & Gene Therapy Trailblazers - Process Development - Chapter 2: ‘DEVELOP & INDUSTRIALIZE’
Sponsored
Sponsored
View Detailed Profile
Three Challenges When Developing a Cell and Gene Therapy - Margit Holzer

Three Challenges When Developing a Cell and Gene Therapy - Margit Holzer

Educo Life Sciences' trainer

Three Challenges When Developing a Cell and Gene Therapy - Melody Janssen

Three Challenges When Developing a Cell and Gene Therapy - Melody Janssen

Educo Life Sciences' trainer Melody discusses

Sponsored
Top Three Tips When Moving into Cell & Gene Therapies - Margit Holzer

Top Three Tips When Moving into Cell & Gene Therapies - Margit Holzer

Educo Life Science trainer,

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

Our experts reveal the first of

2025 MRCT Center Annual Symposium  |  Panel 03: Cell and Gene Therapies Long-Term Follow-Up (LTFU)

2025 MRCT Center Annual Symposium | Panel 03: Cell and Gene Therapies Long-Term Follow-Up (LTFU)

On October 22, 2025, the MRCT Center convened stakeholders from across the clinical research ecosystem at Ropes & Gray in ...

Sponsored
Cell and Gene Therapy (CGT) in the Community: Challenges and Opportunities

Cell and Gene Therapy (CGT) in the Community: Challenges and Opportunities

Gary L. Simmons, DO, MSHA—physician and entrepreneur in a Virginia community practice—dives into the rapidly evolving world ...

Three challenges to commercializing cell therapy

Three challenges to commercializing cell therapy

Christopher Bravery Ph.D., Director of Consulting at Advanced Biologicals Ltd., explains how to overcome the

Biopharmaceutical Career Advice with Margit Holzer - Future Trends

Biopharmaceutical Career Advice with Margit Holzer - Future Trends

Educo Life Sciences' trainer,

FDA Roundtable on Cell and Gene Therapy

FDA Roundtable on Cell and Gene Therapy

Captioning Link: https://bit.ly/4dQaNaz.

Gene Therapy Landscape From the World of CGT (Part-2)

Gene Therapy Landscape From the World of CGT (Part-2)

This month's Insights Corner highlights how

Cell & Gene Therapy Trailblazers - Process Development - Chapter 3: ‘DELIVER TO GMP’

Cell & Gene Therapy Trailblazers - Process Development - Chapter 3: ‘DELIVER TO GMP’

Our experts reveal the

Cell & Gene Therapy Trailblazers - Process Development - Chapter 2: ‘DEVELOP & INDUSTRIALIZE’

Cell & Gene Therapy Trailblazers - Process Development - Chapter 2: ‘DEVELOP & INDUSTRIALIZE’

Our experts reveal the second of

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

The global pharmaceutical industry is constantly innovating, looking forward to discover the next class of

Addressing the Challenges of Therapeutic Vector Development

Addressing the Challenges of Therapeutic Vector Development

The dynamic landscape of molecular biology has bolstered

The challenges of CMC in cell and gene therapies

The challenges of CMC in cell and gene therapies

Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ...

9 Challenges During Cell and Gene Therapy Development in Europe, and How to Tackle Them

9 Challenges During Cell and Gene Therapy Development in Europe, and How to Tackle Them

Download the full webinar here: ...

The main benefits and challenges of gene therapy for sickle cell disease

The main benefits and challenges of gene therapy for sickle cell disease

Akshay Sharma, MBBS, MSc, St. Jude Children's Research Hospital, Memphis, TN, highlights the main benefits of

Innovative Approaches for Gene Therapy Long-Term Follow-Up

Innovative Approaches for Gene Therapy Long-Term Follow-Up

On Tuesday May 6, 2025, The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT ...

Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial

Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial

Cell